NM_182511.4:c.-166-135C>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_182511.4(CBLN2):​c.-166-135C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.008 in 184,812 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0083 ( 14 hom., cov: 31)
Exomes 𝑓: 0.0065 ( 1 hom. )

Consequence

CBLN2
NM_182511.4 intron

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.671

Publications

1 publications found
Variant links:
Genes affected
CBLN2 (HGNC:1544): (cerebellin 2 precursor) Predicted to be involved in maintenance of synapse structure and spontaneous synaptic transmission. Predicted to act upstream of or within positive regulation of synapse assembly. Predicted to be located in extracellular space. Predicted to be active in glutamatergic synapse. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 18-72542461-G-T is Benign according to our data. Variant chr18-72542461-G-T is described in ClinVar as Likely_benign. ClinVar VariationId is 1316642.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.00832 (1265/151966) while in subpopulation SAS AF = 0.0394 (189/4800). AF 95% confidence interval is 0.0348. There are 14 homozygotes in GnomAd4. There are 647 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 14 gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_182511.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CBLN2
NM_182511.4
MANE Select
c.-166-135C>A
intron
N/ANP_872317.1Q8IUK8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CBLN2
ENST00000269503.9
TSL:1 MANE Select
c.-166-135C>A
intron
N/AENSP00000269503.4Q8IUK8
CBLN2
ENST00000585159.5
TSL:1
c.-166-135C>A
intron
N/AENSP00000463771.1Q8IUK8
CBLN2
ENST00000881350.1
c.-301C>A
5_prime_UTR
Exon 1 of 3ENSP00000551409.1

Frequencies

GnomAD3 genomes
AF:
0.00832
AC:
1264
AN:
151848
Hom.:
13
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00247
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00917
Gnomad ASJ
AF:
0.00519
Gnomad EAS
AF:
0.0228
Gnomad SAS
AF:
0.0391
Gnomad FIN
AF:
0.00151
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00977
Gnomad OTH
AF:
0.00814
GnomAD4 exome
AF:
0.00652
AC:
214
AN:
32846
Hom.:
1
AF XY:
0.00616
AC XY:
107
AN XY:
17358
show subpopulations
African (AFR)
AF:
0.00391
AC:
3
AN:
768
American (AMR)
AF:
0.00629
AC:
6
AN:
954
Ashkenazi Jewish (ASJ)
AF:
0.00523
AC:
6
AN:
1148
East Asian (EAS)
AF:
0.0172
AC:
18
AN:
1048
South Asian (SAS)
AF:
0.0317
AC:
9
AN:
284
European-Finnish (FIN)
AF:
0.000303
AC:
1
AN:
3304
Middle Eastern (MID)
AF:
0.00562
AC:
1
AN:
178
European-Non Finnish (NFE)
AF:
0.00693
AC:
160
AN:
23104
Other (OTH)
AF:
0.00486
AC:
10
AN:
2058
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
11
22
32
43
54
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00832
AC:
1265
AN:
151966
Hom.:
14
Cov.:
31
AF XY:
0.00871
AC XY:
647
AN XY:
74282
show subpopulations
African (AFR)
AF:
0.00246
AC:
102
AN:
41462
American (AMR)
AF:
0.00916
AC:
140
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00519
AC:
18
AN:
3466
East Asian (EAS)
AF:
0.0233
AC:
118
AN:
5074
South Asian (SAS)
AF:
0.0394
AC:
189
AN:
4800
European-Finnish (FIN)
AF:
0.00151
AC:
16
AN:
10594
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00977
AC:
664
AN:
67966
Other (OTH)
AF:
0.00758
AC:
16
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
71
142
212
283
354
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00907
Hom.:
1
Bravo
AF:
0.00745
Asia WGS
AF:
0.0310
AC:
107
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
4.1
DANN
Benign
0.83
PhyloP100
0.67
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76871698; hg19: chr18-70209696; API